文献速递膀胱癌与上尿路尿路上皮癌

卡介苗灌注时机对经尿道膀胱肿瘤电切术后肿瘤学生存的影响

Effect of Bacillus Calmette-Guérin Instillation Timing on Oncological Survivals After Transurethral Resection of Bladder Tumor.
PubMed 文献 · Urology · 2024-12-11

该研究基于土耳其泌尿肿瘤协会膀胱癌数据库,回顾性分析12个中心2003至2023年间292例原发性T1高危非肌层浸润性膀胱癌患者,评估经尿道膀胱肿瘤电切术后卡介苗灌注时机对无复发生存和进展生存的影响。中位灌注时机38.5天,中位随访38.4个月,单因素分析显示灌注时机>27.5天与较短的无复发生存和进展生存相关(P=.05)。

要点

  • 延迟卡介苗灌注(>27.5天)与T1高危患者较短的无复发生存和进展生存相关。
  • 卡介苗相关副作用与灌注时机无关联(P=.313)。
  • 作者认为术后4周内应完成卡介苗灌注。

核心结论

  • 在这项回顾性非随机研究中,作者表明卡介苗延迟灌注对T1高危患者的进展和复发有负面影响,因此认为术后4周内应进行卡介苗灌注。

研究设计与样本

  • 回顾性非随机研究,数据来自土耳其泌尿肿瘤协会膀胱癌数据库(UroCaD-B),纳入12个中心2003至2023年间292例接受经尿道膀胱肿瘤电切术和维持卡介苗治疗的原发性T1高危患者。

主要发现

  • 共随访292例患者,其中男性占86%(n=251)。
  • 中位卡介苗灌注时机为38.5天(19-73天),中位随访时间为38.4个月(21.5-72.1个月)。
  • 随访期间,55例(18.5%)患者发现复发,22例(7.5%)患者发现进展。
  • 单因素Cox回归分析显示,长灌注时机(>27.5天)对较短的无复发生存和进展生存风险有统计学显著影响(P=.05)。
  • Kaplan-Meier分析显示,不同灌注时机组间的无复发生存和进展生存有显著差异(P=.04,P=.011)。

关键数值与推荐

  • 长卡介苗灌注时机定义为>27.5天。
  • 卡介苗相关副作用与灌注时机无关联(P=.313)。

临床怎么用

  • 作者认为,T1高危患者术后4周内应进行卡介苗灌注。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether the timing of bacillus Calmette-Guerin instillation (TTBCG), which plays a key role in treating non-muscle invasive bladder cancer (NMIBC), after transurethral resection of bladder tumor (TURBT) affects oncologic outcomes. METHODS: Patient data obtained from the Urologic Cancer Database-Bladder (UroCaD-B) of Turkish Uro-oncology Association (TUOA) were evaluated. Data from 292 patients from 12 centers with primary T1HG treated with TURBT and maintenance BCG between 2003 and 2023 were retrospectively analyzed. The population was subdivided according to TTBCG, while recurrence-free survival (RFS) and progression-free survival (PFS) were estimated by log-rank tests and univariable and multivariable regression analyses. RESULTS: A total of 292 patients were followed, and 86% (n=251) of those included in the study were male. The median duration of TTBCG was 38.5 days (19-73). The median follow-up period was 38.4 months (21.5-72.1 months). During follow-up, recurrence was detected in 55 (18.5%) patients and progression was detected in 22 (7.5%) patients. In univariate Cox regression analysis, long TTBCG (>27.5 days) was found to have a statistically significant effect on the risk of short RFS and PFS (P=.05). BCG-related side effects were not associated with TTBCG (P=.313). Kaplan-Meier analysis showed that there was a significant difference in RFS and PFS between the TTBCG groups (P=.04, P=.011, respectively). CONCLUSION: In this retrospective non-randomized study, we showed the negative effects of BCG delay on progression and recurrence in T1HG patients. Therefore, we think that BCG should be instilled within 4 weeks after surgery.

来源:Urology,查看原文。版权归原作者所有。

引用

  1. Çetin T, Bolat D, Akgül M, et al. Effect of Bacillus Calmette-Guérin Instillation Timing on Oncological Survivals After Transurethral Resection of Bladder Tumor. Urology. 2024. PMID: 39672342. doi:10.1016/j.urology.2024.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。